# Research Idea Ranking

**Generated:** 2026-02-20T10:01:22.357535
**Model:** openai/gpt-5.2 (reasoning: high)
**Tokens:** 7624

---

### Rankings

**#1: Does Water Access Build Human Capital? Evidence from India's Jal Jeevan Mission (JJM)**
- **Score: 72/100**
- **Strengths:** Very large-scale policy with rich within-India variation and a long, high-frequency pre-period in nightlights that supports credible event-study diagnostics. Novel in the sense that JJM is recent and causal evidence is still sparse, especially beyond mortality.
- **Concerns:** Treatment intensity based on *baseline piped-water deficits* risks endogeneity (districts with low baseline coverage may have different trends, governance capacity, or COVID exposure). Nightlights are an indirect proxy and are likely *urban-weighted*, creating potential outcome dilution for a rural water program.
- **Novelty Assessment:** **High.** JJM is new; there are not “100 papers” on it yet. Water/human capital is well-studied generally, but *this specific program + district-month panel + event study* is still meaningfully under-explored.
- **DiD Assessment (nightlights panel as the primary design):**
  - **Pre-treatment periods:** **Strong** (2013–2019 monthly)
  - **Selection into treatment:** **Marginal** (allocation plausibly tied to baseline deficits and administrative capacity; not quasi-random)
  - **Comparison group:** **Marginal** (high- vs low-baseline-coverage districts differ structurally)
  - **Treatment clusters:** **Strong** (~640 districts)
  - **Concurrent policies:** **Marginal** (COVID and other rural initiatives overlap 2020–2021; time FE absorb common shocks but heterogeneous COVID impacts remain a concern)
  - **Outcome-Policy Alignment:** **Marginal** (nightlights proxy “development/economic activity,” not human capital per se; NFHS health/education indicators align better but are not clean panel outcomes)
  - **Data-Outcome Timing:** **Strong (if implemented month-specifically)** (JJM starts Aug 2019; nightlights monthly—can code exposure by month rather than “post-2019”)
  - **Outcome Dilution:** **Marginal** (JJM is rural; district nightlights are disproportionately driven by towns—need rural-pixel nightlights or rural-share weighting)
- **Recommendation:** **PURSUE (conditional on: (i) using district-month JJM coverage/connection trajectories rather than a single baseline-intensity proxy; (ii) explicitly addressing COVID heterogeneity—e.g., controls/interactions or robustness excluding 2020–2021; (iii) mitigating dilution via rural-only nightlights or excluding highly urban districts; (iv) treating NFHS-4 vs NFHS-5 as a secondary, timing-aware supplement—NFHS-5 fieldwork overlaps pre/post in many places).**

---

**#2: Free Rides, Free Women? The Labor Market Effects of India’s Free Bus Travel Schemes**
- **Score: 48/100**
- **Strengths:** Extremely policy-relevant and (likely) genuinely novel; outcomes are directly aligned (female labor supply) and PLFS is the right kind of microdata if identification were stronger.
- **Concerns:** DiD credibility is weak: only **7 treated states**, early treatment leaves **≤2 true pre-periods** for Delhi, and adoption is politically chosen (selection on trends highly plausible). Annual PLFS creates timing/exposure problems for mid-year rollouts, and COVID overlaps the core treatment window for early adopters.
- **Novelty Assessment:** **Very high.** I am not aware of clean causal papers on these Indian state free-fare programs; most existing work is descriptive.
- **DiD Assessment:**
  - **Pre-treatment periods:** **Weak** (Delhi treated Oct 2019; PLFS begins 2017–18 → ~2 pre years)
  - **Selection into treatment:** **Weak** (political/electoral adoption; could respond to women’s employment trends or urban congestion)
  - **Comparison group:** **Marginal** (untreated states differ systematically; large urban states vs others)
  - **Treatment clusters:** **Weak** (7 treated states; cluster-robust inference fragile even with wild bootstrap)
  - **Concurrent policies:** **Weak** (COVID period + other state welfare schemes; hard to separate)
  - **Outcome-Policy Alignment:** **Strong** (transport cost ↓ should affect women’s labor supply and job search)
  - **Data-Outcome Timing:** **Marginal** (annual PLFS means partial-year exposure in “treatment year” for many states; needs careful assignment)
  - **Outcome Dilution:** **Marginal** (policy targets women, but only those with bus access/usage; effects diluted in rural areas and among non-commuters)
- **Recommendation:** **SKIP (unless redesigned).** A credible path would require a different design that fixes the “few treated clusters + short pre” problem (e.g., city-level implementations with many cities, ticketing/route-level discontinuities, or higher-frequency labor/commuting outcomes with clear exposure timing).

---

**#3: Lighting the Path: Rural Broadband and Economic Activity in India (BharatNet)**
- **Score: 45/100**
- **Strengths:** High policy relevance (digital inclusion) and potentially massive sample size if GP-level rollout dates are truly obtainable. There is room for India-specific causal evidence even though broadband impacts are studied globally.
- **Concerns:** Data feasibility is currently the binding constraint (bulk GP connectivity dates and reliable “go-live/usable service” measures). Identification is also weak with only ~2 pre-years before the earliest 2015 rollout and substantial targeting/selection into early connectivity; district-level nightlights further risk severe dilution.
- **Novelty Assessment:** **Moderate.** “Broadband → growth” is a crowded literature internationally; India-specific BharatNet causal work is less common, but not virgin territory conceptually.
- **DiD Assessment (as written):**
  - **Pre-treatment periods:** **Weak** (nightlights start 2013; BharatNet begins 2015 → ~2 pre years for earliest treated)
  - **Selection into treatment:** **Marginal** (rollout plausibly targeted by feasibility, politics, and baseline development)
  - **Comparison group:** **Marginal** (late-connected GPs likely differ from early-connected ones)
  - **Treatment clusters:** **Strong** (if GP-level is real: tens/hundreds of thousands of units)
  - **Concurrent policies:** **Marginal** (major coincident digital shocks: Jio expansion, demonetization, UPI growth—hard to net out with simple DiD)
  - **Outcome-Policy Alignment:** **Marginal** (nightlights proxy; broadband effects may show up in specific margins not well-captured by aggregate lights)
  - **Data-Outcome Timing:** **Strong (potentially)** (nightlights monthly; if “service-ready date” is known precisely)
  - **Outcome Dilution:** **Weak** if outcomes are **district-level** nightlights (GP broadband affects a small share of district light); could become **Marginal/Strong** only with high-resolution local outcomes (GP/buffer-level)
- **Recommendation:** **SKIP (unless key feasibility/ID fixes occur):** confirm bulk GP rollout + a credible “usable broadband” date; construct GP-level (or 1–5km buffer) nightlights to reduce dilution; and focus on later rollout waves (post-2017/2018) to build ≥5 pre-years for those cohorts.

---

**#4: Does Ration Card Portability Reduce Food Insecurity Among Migrants? Evidence from ONORC**
- **Score: 20/100**
- **Strengths:** Very important policy question in principle, and ONORC is a major reform.
- **Concerns:** The proposed DiD is essentially broken: adoption is heavily compressed into 2019–2020 and is fundamentally confounded by COVID; pre-periods are too short; and (as stated) **interstate** transaction take-up is tiny, implying severe outcome dilution / “treatment barely occurred.”
- **Novelty Assessment:** **Moderate.** There are fewer causal papers than you might expect, but the idea has been discussed widely; novelty cannot compensate for weak identification and implementation intensity.
- **DiD Assessment:**
  - **Pre-treatment periods:** **Weak** (≈2 years)
  - **Selection into treatment:** **Marginal** (central push helps, but timing still not credibly exogenous)
  - **Comparison group:** **Weak** (near-universal rapid adoption leaves little valid comparison)
  - **Treatment clusters:** **Strong** (36 states/UTs)
  - **Concurrent policies:** **Weak** (COVID is a dominant, heterogeneous shock exactly during rollout)
  - **Outcome-Policy Alignment:** **Marginal/Weak** (PLFS is not a clean food insecurity measure; HCES timing/availability is sporadic)
  - **Data-Outcome Timing:** **Weak** (rollout and pandemic timing make “first treated year” exposure unclear)
  - **Outcome Dilution:** **Weak** (tiny interstate usage relative to total PDS activity; migrant-targeted effects diluted in state aggregates)
- **Recommendation:** **SKIP.**

---

### Summary

This batch has **one clearly promising project (JJM)** that combines genuine novelty with strong panel structure and enough pre-periods to do serious event-study validation—though it needs careful handling of endogeneity, COVID-era confounding, and rural/urban outcome dilution. The **free bus** and **BharatNet** ideas are interesting and policy-relevant but currently fail core DiD credibility checks (few treated clusters / short pre-periods / dilution and feasibility), and **ONORC** is not salvageable in its current form given compressed adoption + COVID + low effective treatment intensity.